Category: Series
-
Medexus Pharmaceutical (MDP.T) readies for powerful year of growth in specialty pharma sector
Big pharma firms like Abbvie can offer incredible product growth potential to investors, but they also saddle shareholders with tremendous risk in terms of regulatory approval and capital cost. According to a recent study which tracked the success rates of clinical drug development through to FDA approval between 2006-2015, just 9.6% of the drug candidates…
-
Why Verses Technologies (VERS.NEO) share price doubled since IPO 5 weeks ago
Verses Technologies (VERS.NEO) is a next-generation AI company providing foundational technology for the contextual computing era. Modeled after natural systems and the design principles of the human brain and the human experience, VERSES’ flagship offering, COSM, is an AI Operating System for enhancing any application with adaptive intelligence. That’s a mouthful. The objective of Verses’…
-
The Fed raises rates by 75 basis points for the second consecutive time. What does this mean for stock markets?
In one word: bullish. The stock markets are loving the hawkish Fed. The Federal Reserve has raised interest rates by 75 basis points for the second consecutive time. The stock markets largely had this rate hike priced in. Fed futures had a near 100% probability of a 75 basis point hike and the Fed tends…
-
Medexus (MDP.T) resubmits Treosulfan NDA to FDA
Medexus (MDP.T), a Canadian-based specialty pharma firm focused on acquiring and distributing innovative rare disease treatment solutions in North America, announced today that its strategic partner, medac, had resubmitted its New Drug Application (NDA) for treosulfan to the U.S. Food and Drug Administration. This submission was a response to the FDA request to submit information…
-
How Do Rising Interest Rates Affect You?
Shalom, my darlings. Since we last spoke, I’ve been extremely preoccupied changing my entire personality after spending exactly one month in Europe. I now wear a necklace engraved with my Hebrew name, begin my newsletters with “Shalom, my darlings”, and not-at-all casually begin every other sentence with “Oh, well when I was in Israel…” (strong…
-
Is this the best way to invest in gold and silver?
We have a major week ahead with the Federal Reserve and potential confirmation of a US recession. Is now the time to look at gold? It gets a bit more complicated. Sure, money can run into gold when there is fear and uncertainty, but there are some typical money flow signs that I watch for.…
-
How to invest when you don’t know what to do
Inflation. Deflation. Stagflation. Markets going down week after week, only to rip up higher. Headlines don’t seem to line up and so-called experts, who claim to have seen it all before, have as many different views as there are Elon Musk lawsuits. When there are too many signals and the immediate road ahead isn’t clear,…
-
Have US stock markets established their bear market lows?
Have US stock markets bottomed? From a technical analysis perspective: yes, there is a very good chance they have. From a fundamental perspective: it gets complicated. If we consider fundamentals, there is a lot which can weigh in on markets. Some things to consider are: Earnings, China, Russia, Inflation, Interest Rates, Supply Chain Issues, European…
-
There could be more pain before the market actually turns
Newsfeeds are clogged with “the bottom’s here!” narrative and we’re already seeing a significant bump in positivity in the public markets including risk-on assets like cryptocurrency, but are we out of the woods? This stream of social media ‘good news’ and bullish fervor comes as the yield curve inversion is in full swing. It might…